MS CD49d+CD154+ Lymphocytes Reprogram Oligodendrocytes into Immune Reactive Cells Affecting CNS Regeneration
Paweł Piatek1, Magdalena Namiecinska1, Małgorzata Domowicz1
1Department of Neurology, Laboratory of Neuroimmunology, Medical University of Lodz, Poland, Pomorska Str. 251, 92-213 Lodz, Poland.
Multiple sclerosis (MS) involves impaired central nervous system (CNS) regeneration. Myelin-specific lymphocytes hinder oligodendrocyte maturation and myelin synthesis, offering new therapeutic targets for remyelination.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Multiple sclerosis (MS) progression is linked to insufficient central nervous system (CNS) regeneration due to poor myelin synthesis by oligodendrocytes (OLs).
- While T-cell mediated inflammation is studied, the challenge of inadequate remyelination and disease progression persists.
Purpose of the Study:
- To investigate the impact of myelin-specific lymphocytes on oligodendrocyte (OL) function in MS patients and a mouse model of MS.
- To identify molecular mechanisms underlying lymphocyte-induced OL dysfunction and explore therapeutic targets.
Main Methods:
- Co-culture of myelin-specific CD49d+CD154+ lymphocytes from MS patients and Experimental Autoimmune Encephalomyelitis (EAE) mouse T and B cells with oligodendrocyte precursor cells (OPCs).
- Analysis of OPC maturation, myelin protein (MBP, PLP) synthesis, and inflammatory mediator production.
- Investigation of microRNA (miRNA) synthesis and polymerase II activity in OLs.
Main Results:
- Myelin-specific CD49d+CD154+ lymphocytes induced immune-reactive OLs with imbalanced MBP/PLP production and pro-inflammatory cytokine synthesis.
- Lymphocytes dysregulated miRNA synthesis in OLs, primarily targeting miR-665 and ELL3.
- Neutralizing elevated intracellular miR-665 restored normal miRNA and MBP/PLP synthesis.
Conclusions:
- MS-associated myelin-specific lymphocytes impair oligodendrocyte maturation and myelin synthesis.
- Dysregulation of miR-665 by lymphocytes is a key mechanism driving impaired remyelination.
- Targeting miR-665 presents a potential therapeutic strategy to promote CNS remyelination in MS.
More Related Videos
09:05Generation of Oligodendrocytes and Oligodendrocyte-Conditioned Medium for Co-Culture Experiments
Published on: February 9, 2020
10:53Generation of Human Neurons and Oligodendrocytes from Pluripotent Stem Cells for Modeling Neuron-Oligodendrocyte Interactions
Published on: November 9, 2020
